A Phase 2b Study of Modified Vaccinia Virus to Treat Patients Advanced Liver Cancer Who Failed Sorafenib (TRAVERSE)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01387555 |
Recruitment Status :
Completed
First Posted : July 4, 2011
Last Update Posted : March 11, 2015
|
Sponsor:
Jennerex Biotherapeutics
Information provided by (Responsible Party):
Jennerex Biotherapeutics
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Completed |
---|---|
Actual Primary Completion Date : | December 2011 |
Actual Study Completion Date : | December 2011 |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):